Annual EBITDA
-$46.35M$293.86M+86.37%
Summary
- Current Value
- As of today, ARGX annual EBITDA is -$46.35M, up +86.37% on
- Historical Performance
- ARGX annual EBITDA is up +87.53% over the past 3 years, and up +77.56% over the past 5 years
- All-Time High Comparison
- ARGX annual EBITDA is currently -520.22% below its historical high of -$7.47M set on
- 3-Year Low Comparison
- ARGX annual EBITDA is +92.78% above its 3-year low of -$641.62M reached on an earlier date
- Sector Comparison
- ARGX annual EBITDA is higher than 31.69% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$46.35M | +86.4% | +87.5% | +77.6% | – | |
| Quarterly EBITDA | $388.89M | +610.0% | – | +275.3% | +10000.0% | |
| TTM EBITDA | $923.95M | +1586.9% | – | +516.4% | +10000.0% | |
| Price | $822.94 | +26.9% | +119.0% | +186.9% | – | |
| PE Ratio | 106.05 | – | – | – | – | |
| Annual Revenue | $2.19B | +78.0% | +340.4% | +2699.3% | – | |
| Annual EPS | $12.76 | +346.8% | +259.9% | +370.1% | – | |
| Annual EBIT | -$63.85M | +85.9% | +83.1% | +69.5% | – | |
| Annual Net Income | $831.57M | +381.4% | +304.0% | +555.9% | – |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$46.35M | at high | |
| 5Y | -$46.35M | at high | |
| All | -$7.47M | -520.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$641.62M | N/A | +92.8% |
| 5Y | -$641.62M | +92.8% | |
| All | -$641.62M | +92.8% |
EBITDA History
FAQ
What is the current annual EBITDA of ARGX?
As of today, ARGX annual EBITDA is -$46.35M
What is 1-year change in ARGX annual EBITDA?
ARGX annual EBITDA is up +86.37% year-over-year
What is 3-year change in ARGX annual EBITDA?
ARGX annual EBITDA is up +87.53% over the past 3 years
How far is ARGX annual EBITDA from its all-time high?
ARGX annual EBITDA is currently -520.22% below its historical high of -$7.47M set on December 31, 2011
How does ARGX annual EBITDA rank versus sector peers?
ARGX annual EBITDA is higher than 31.69% of companies in Healthcare sector
When is ARGX next annual earnings release?
The next annual earnings release for ARGX is on
Quarterly EBITDA
$388.89M$149.43M+62.40%
Summary
- Current Value
- As of today, ARGX quarterly EBITDA is $388.89M, up +62.40% on
- Historical Performance
- ARGX quarterly EBITDA is up +610.01% year-over-year, with unknown 3-year change
- All-Time High Comparison
- ARGX quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ARGX quarterly EBITDA is +610.01% above its 3-year low of $54.77M reached on
- Sector Comparison
- ARGX quarterly EBITDA is higher than 94.31% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $388.89M | +62.4% | +610.0% | – | +275.3% | |
| Annual EBITDA | -$46.35M | – | +86.4% | +87.5% | +77.6% | |
| TTM EBITDA | $923.95M | +56.6% | +1586.9% | – | +516.4% | |
| Price | $822.94 | +3.2% | +26.9% | +119.0% | +186.9% | |
| PE Ratio | 106.05 | +3.2% | – | – | – | |
| Quarterly Revenue | $1.13B | +18.9% | +96.7% | – | +4713.6% | |
| Quarterly EPS | $5.18 | – | +272.7% | +840.0% | +218.8% | |
| Quarterly EBIT | $387.05M | +34.4% | +336.4% | – | +268.9% | |
| Quarterly Net Income | $344.26M | +40.3% | +276.6% | – | +251.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $388.89M | at high | |
| 3Y | $388.89M | at high | |
| 5Y | $388.89M | at high | |
| All | $388.89M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $119.53M | N/A | +225.3% |
| 3Y | $54.77M | +610.0% | |
| 5Y | -$221.91M | +275.3% | |
| All | -$221.91M | +275.3% |
Quarterly EBITDA History
| Month | Value | Change |
|---|---|---|
| $388.89M | +62.4% | |
| $239.46M | +36.0% | |
| $176.06M | +47.3% | |
| $119.53M | +118.2% |
| Month | Value | Change |
|---|---|---|
| $54.77M | +132.3% | |
| -$169.63M | +23.6% | |
| -$221.91M | - |
FAQ
What is the current quarterly EBITDA of ARGX?
As of today, ARGX quarterly EBITDA is $388.89M
What is ARGX quarterly EBITDA most recent change?
ARGX quarterly EBITDA was up +62.40% on September 30, 2025
What is 1-year change in ARGX quarterly EBITDA?
ARGX quarterly EBITDA is up +610.01% year-over-year
How far is ARGX quarterly EBITDA from its all-time high?
ARGX quarterly EBITDA is currently at its all-time high
How does ARGX quarterly EBITDA rank versus sector peers?
ARGX quarterly EBITDA is higher than 94.31% of companies in Healthcare sector
When is ARGX next earnings release?
The next earnings release for ARGX is on
TTM EBITDA
$923.95M$334.12M+56.65%
Summary
- Current Value
- As of today, ARGX TTM EBITDA is $923.95M, up +56.65% on
- Historical Performance
- ARGX TTM EBITDA is up +1586.86% year-over-year, with unknown 3-year change
- All-Time High Comparison
- ARGX TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ARGX TTM EBITDA is +1586.86% above its 3-year low of $54.77M reached on
- Sector Comparison
- ARGX TTM EBITDA is higher than 92.87% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $923.95M | +56.6% | +1586.9% | – | +516.4% | |
| Annual EBITDA | -$46.35M | – | +86.4% | +87.5% | +77.6% | |
| Quarterly EBITDA | $388.89M | +62.4% | +610.0% | – | +275.3% | |
| Price | $822.94 | +3.2% | +26.9% | +119.0% | +186.9% | |
| PE Ratio | 106.05 | +3.2% | – | – | – | |
| TTM Revenue | $3.60B | +18.2% | +529.0% | – | +10000.0% | |
| TTM EPS | $7.76 | – | +458.3% | +187.6% | +278.0% | |
| TTM EBIT | $965.78M | +44.7% | +988.8% | – | +521.5% | |
| TTM Net Income | $1.53B | +19.8% | +1577.3% | – | +774.9% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $923.95M | at high | |
| 3Y | $923.95M | at high | |
| 5Y | $923.95M | at high | |
| All | $923.95M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $174.31M | N/A | +430.1% |
| 3Y | $54.77M | +1586.9% | |
| 5Y | -$391.54M | +336.0% | |
| All | -$391.54M | +336.0% |
TTM EBITDA History
| Month | Value | Change |
|---|---|---|
| $923.95M | +56.6% | |
| $589.82M | +68.3% | |
| $350.36M | +101.0% | |
| $174.31M | +218.2% |
| Month | Value | Change |
|---|---|---|
| $54.77M | +114.0% | |
| -$391.54M | -76.4% | |
| -$221.91M | - |
FAQ
What is the current TTM EBITDA of ARGX?
As of today, ARGX TTM EBITDA is $923.95M
What is ARGX TTM EBITDA most recent change?
ARGX TTM EBITDA was up +56.65% on September 30, 2025
What is 1-year change in ARGX TTM EBITDA?
ARGX TTM EBITDA is up +1586.86% year-over-year
How far is ARGX TTM EBITDA from its all-time high?
ARGX TTM EBITDA is currently at its all-time high
How does ARGX TTM EBITDA rank versus sector peers?
ARGX TTM EBITDA is higher than 92.87% of companies in Healthcare sector
When is ARGX next earnings release?
The next earnings release for ARGX is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ARGX Official Website argenx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1697862/000169786225000024/0001697862-25-000024-index.htm
- ARGX Profile on Yahoo Finance finance.yahoo.com/quote/ARGX
- ARGX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/argx